Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Androgenotherapy for Post-Remission Treatment of Elderly Patients With Acute Myeloid Leukemia
NCT00700544Phase 3Completed
- Sponsor
- CHU Grenoble Alpes
- Start
- Jun 2002
- Primary completion
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of norethandrolone in acute myeloid leukemia (AML) (2 arms), sponsored by CHU Grenoble Alpes. Primary endpoint: Disease-Free Survival at 3 years. Started Jun 2002; status: completed.
02
Drugs
norethandrolone
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00700544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00700544.